Nav: Home

New in the Hastings Center Report May-June 2017

May 31, 2017

Defending Opioid Treatment Agreements: Disclosure, Not Promises
Joshua B. Rager and Peter H. Schwartz

To receive controlled pain medications for chronic pain, patients often must sign a "narcotic contract" or "opioid treatment agreement" in which they promise, among other things, not to give pills to others or use illegal drugs. While the aim is to address the widespread abuse and misuse of narcotic pain medication, critics argue that these agreements are ethically suspect, if not unethical. The authors conclude, however, that the most serious criticisms stem from a misunderstanding of the agreements' purpose. Specifically, that purpose is not to justify the system of monitoring and supervision but instead to disclose its requirements to patients. Joshua B. Rager is a medical student at the Indiana University School of Medicine. Peter H. Schwartz is a physician and the interim director of the Indiana University Center for Bioethics.

Other Voices:

Given the uncertainty regarding the safety and efficacy of opioid painkillers, as well as insufficient training for prescribers and inadequate patient education, Anita Ho proposes replacing OTAs with opioid treatment plans, which would promote mutual, collaborative, and shared decision-making on the most appropriate pain management program, one that would hold all parties accountable. Richard Payne, a physician, believes that physicians will continue to use OTAs as protection against litigation and sanctions by medical boards, at the expense of patients in pain.

How to Rethink the Fourteen-Day Rule
Sarah Chan

Recently, attention has been drawn to the basic principles governing the use of human embryos in research: specifically, the so-called 14-day rule, which stipulates that human embryos should not be allowed to grow in vitro past 14 days of development. For years, the 14-day limit was largely theoretical, since it was not possible to maintain embryos up to this point. But in the past year, research has suggested that growing embryos for a longer period might be feasible and scientifically valuable. At the same time, other research raises the possibility that pluripotent stem cells, including human PSCs, could be used to generate embryo-like structures in vitro, even "synthetic embryos," that might provoke moral concern but would not fall under most current embryo research policies. Any moves to change the 14-day rule must consider not just the implications for the use of embryos but also the potential impact of this model of bioethical governance of science. Sarah Chan is a chancellor's fellow at the University of Edinburgh.
Also in this issue: Contact Susan Gilbert, director of communications
The Hastings Center
845-424-4040 x244

The Hastings Center

Related Pain Articles:

It's not just a pain in the head -- facial pain can be a symptom of headaches too
A new study finds that up to 10% of people with headaches also have facial pain.
New opioid speeds up recovery without increasing pain sensitivity or risk of chronic pain
A new type of non-addictive opioid developed by researchers at Tulane University and the Southeast Louisiana Veterans Health Care System accelerates recovery time from pain compared to morphine without increasing pain sensitivity, according to a new study published in the Journal of Neuroinflammation.
The insular cortex processes pain and drives learning from pain
Neuroscientists at EPFL have discovered an area of the brain, the insular cortex, that processes painful experiences and thereby drives learning from aversive events.
Pain, pain go away: new tools improve students' experience of school-based vaccines
Researchers at the University of Toronto and The Hospital for Sick Children (SickKids) have teamed up with educators, public health practitioners and grade seven students in Ontario to develop and implement a new approach to delivering school-based vaccines that improves student experience.
Pain sensitization increases risk of persistent knee pain
Becoming more sensitive to pain, or pain sensitization, is an important risk factor for developing persistent knee pain in osteoarthritis (OA), according to a new study by researchers from the Université de Montréal (UdeM) School of Rehabilitation and Hôpital Maisonneuve Rosemont Research Centre (CRHMR) in collaboration with researchers at Boston University School of Medicine (BUSM).
More Pain News and Pain Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...